Kevin Fischbeck
Stock Analyst at B of A Securities
(4.03)
# 464
Out of 5,182 analysts
188
Total ratings
64.39%
Success rate
5.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OPCH Option Care Health | Maintains: Buy | $32 → $35 | $27.74 | +26.17% | 2 | Dec 9, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Underperform | $22 → $13 | $25.39 | -48.80% | 9 | Dec 3, 2025 | |
| ARDT Ardent Health | Maintains: Underperform | $12 → $10 | $9.02 | +10.86% | 4 | Nov 13, 2025 | |
| HUM Humana | Maintains: Neutral | $280 → $300 | $197.15 | +52.17% | 17 | Oct 10, 2025 | |
| ELV Elevance Health | Maintains: Neutral | $330 → $370 | $311.83 | +18.65% | 4 | Oct 10, 2025 | |
| UNH UnitedHealth Group | Maintains: Neutral | $350 → $390 | $307.73 | +26.73% | 27 | Oct 8, 2025 | |
| AMN AMN Healthcare Services | Maintains: Underperform | $20 → $18 | $18.63 | -3.38% | 5 | Sep 10, 2025 | |
| DVA DaVita | Maintains: Underperform | $145 → $140 | $149.70 | -6.48% | 13 | Sep 10, 2025 | |
| THC Tenet Healthcare | Maintains: Buy | $205 → $225 | $194.60 | +15.62% | 8 | Sep 10, 2025 | |
| EHC Encompass Health | Maintains: Buy | $145 → $160 | $105.67 | +51.41% | 2 | Sep 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $52 → $30 | $36.31 | -17.38% | 13 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $215 → $185 | $180.61 | +2.43% | 15 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $394 → $410 | $489.58 | -16.25% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $75 | $16.59 | +352.08% | 2 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $439 | $141.53 | +210.18% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $11.94 | -45.56% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $21.66 | -66.53% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $274.25 | +27.62% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $12.64 | +256.01% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $3.03 | +81.52% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.35 | +114.07% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $1.90 | +426.32% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $9.86 | -23.94% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $21.74 | - | 3 | Sep 6, 2019 |
Option Care Health
Dec 9, 2025
Maintains: Buy
Price Target: $32 → $35
Current: $27.74
Upside: +26.17%
Acadia Healthcare Company
Dec 3, 2025
Downgrades: Underperform
Price Target: $22 → $13
Current: $25.39
Upside: -48.80%
Ardent Health
Nov 13, 2025
Maintains: Underperform
Price Target: $12 → $10
Current: $9.02
Upside: +10.86%
Humana
Oct 10, 2025
Maintains: Neutral
Price Target: $280 → $300
Current: $197.15
Upside: +52.17%
Elevance Health
Oct 10, 2025
Maintains: Neutral
Price Target: $330 → $370
Current: $311.83
Upside: +18.65%
UnitedHealth Group
Oct 8, 2025
Maintains: Neutral
Price Target: $350 → $390
Current: $307.73
Upside: +26.73%
AMN Healthcare Services
Sep 10, 2025
Maintains: Underperform
Price Target: $20 → $18
Current: $18.63
Upside: -3.38%
DaVita
Sep 10, 2025
Maintains: Underperform
Price Target: $145 → $140
Current: $149.70
Upside: -6.48%
Tenet Healthcare
Sep 10, 2025
Maintains: Buy
Price Target: $205 → $225
Current: $194.60
Upside: +15.62%
Encompass Health
Sep 10, 2025
Maintains: Buy
Price Target: $145 → $160
Current: $105.67
Upside: +51.41%
Jul 16, 2025
Downgrades: Underperform
Price Target: $52 → $30
Current: $36.31
Upside: -17.38%
Jul 16, 2025
Downgrades: Underperform
Price Target: $215 → $185
Current: $180.61
Upside: +2.43%
Jul 16, 2025
Downgrades: Neutral
Price Target: $394 → $410
Current: $489.58
Upside: -16.25%
Oct 2, 2024
Downgrades: Underperform
Price Target: $75
Current: $16.59
Upside: +352.08%
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $141.53
Upside: +210.18%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $11.94
Upside: -45.56%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $21.66
Upside: -66.53%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $274.25
Upside: +27.62%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $12.64
Upside: +256.01%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $3.03
Upside: +81.52%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.35
Upside: +114.07%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $1.90
Upside: +426.32%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $9.86
Upside: -23.94%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $21.74
Upside: -